FERDEGHINI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 7.911
EU - Europa 4.233
AS - Asia 3.482
SA - Sud America 414
AF - Africa 29
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 16.092
Nazione #
US - Stati Uniti d'America 7.856
SG - Singapore 1.639
GB - Regno Unito 1.336
CN - Cina 1.154
FI - Finlandia 464
FR - Francia 449
DE - Germania 437
RU - Federazione Russa 406
HK - Hong Kong 390
BR - Brasile 364
IE - Irlanda 342
SE - Svezia 311
IT - Italia 191
UA - Ucraina 168
VN - Vietnam 90
KR - Corea 48
TR - Turchia 34
CA - Canada 32
IN - India 29
BE - Belgio 22
ES - Italia 18
JP - Giappone 16
AT - Austria 15
AR - Argentina 14
BD - Bangladesh 14
MX - Messico 14
PL - Polonia 13
EC - Ecuador 12
NL - Olanda 12
AU - Australia 10
PK - Pakistan 10
IQ - Iraq 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
CO - Colombia 6
DK - Danimarca 6
EG - Egitto 6
EU - Europa 6
ID - Indonesia 6
NP - Nepal 6
LT - Lituania 5
MA - Marocco 5
RO - Romania 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
KZ - Kazakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CL - Cile 3
KE - Kenya 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
LI - Liechtenstein 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
CU - Cuba 1
DJ - Gibuti 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
Totale 16.089
Città #
Jacksonville 1.639
Southend 1.106
Chandler 1.036
Woodbridge 844
Singapore 823
Ann Arbor 589
Dallas 529
Houston 409
Hong Kong 386
Dublin 340
Ashburn 278
Wilmington 188
Lawrence 184
Princeton 184
Nanjing 143
Sindelfingen 131
Boardman 111
New York 111
Los Angeles 100
Helsinki 92
Buffalo 91
Jinan 89
Beijing 88
Shenyang 88
Hebei 85
The Dalles 62
Philadelphia 58
Tianjin 56
Changsha 52
Verona 47
Nanchang 46
Detroit 45
Columbus 42
Haikou 37
Hangzhou 37
Jiaxing 37
Dong Ket 36
Milan 35
Norwalk 35
Ningbo 34
Munich 33
Zhengzhou 33
São Paulo 31
Guangzhou 27
Santa Clara 25
Falls Church 24
Brussels 22
Chicago 22
Taizhou 22
Washington 21
Bologna 20
San Francisco 20
Ho Chi Minh City 18
Auburn Hills 17
Lanzhou 17
Taiyuan 16
Tokyo 16
Dearborn 15
Lancaster 15
Redondo Beach 15
Tappahannock 15
Toronto 15
Düsseldorf 13
Seattle 13
Turku 13
Brooklyn 12
Hanoi 11
Rio de Janeiro 11
Atlanta 10
Chennai 10
Redwood City 10
Stockholm 10
Warsaw 10
Vienna 9
Fuzhou 8
London 8
Boston 7
Charlotte 7
Kent 7
Montreal 7
Phoenix 7
San Diego 7
Vigo 7
Belo Horizonte 6
Curitiba 6
Frankfurt am Main 6
Guarulhos 6
Johannesburg 6
Melbourne 6
Moscow 6
New Delhi 6
Rome 6
Shanghai 6
Ypsilanti 6
Andover 5
Brasília 5
Cairo 5
Edinburgh 5
Fairfield 5
Hanover 5
Totale 11.075
Nome #
[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas 177
Gated reconstruction in 18FDG PET-CT quantitative imaging: impact on SUV estimation in lung tumors 159
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 149
Espressione di Claudina-1 e 7 nel carcinoma papillare della tiroide con comportamento clinico aggressivo 148
A mathematical model of thyroid mass reduction after radioiodine therapy of Graves’ disease 146
SU-E-J-168: 4D-PET for Target Volume Delineation in Respiratory-Gated Radiation Therapy. 143
Humanization of care in pediatrics and built-in psychological support in nuclear medicine [Umanizzazione delle cure in età pediatrica e assistenza psicologica integrata in Medicina nucleare] 142
Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. 137
First human Cerenkography. 133
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal. 131
Role of dual-point FDG PET/CT in prone position and fused PET/MR; correlation with biologic prognostic parameters in breast cancer 129
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 128
Valutazione comparativa dell'acquisizione volumetrica tiroidea con ecografia convenzionale B-Mode (US) ed ecografia volumetrica (VUS) 121
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 121
rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity 120
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma 113
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours 113
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 113
Acute suppression of parathyroid activity during hemofiltration 112
Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits 112
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 111
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology 108
Analytical and clinical assessment of a commercial kit for the simultaneous determination of free thyroxine and thyrotropin 107
[Bromocriptine therapy from the 2d month of pregnancy induces regression of neuro-ophthalmologic complications caused by macroprolactimona] 107
A new luminescence immunoassay for thyrotropin using coated tubes: evaluation and comparison with immunoradiometric assay 106
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in man 106
Relation of fetal growth to maternal responses to oral glucose tolerance test throughout gestation 106
Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study. 106
Optimized PET Imaging for 4D Treatment Planning in Radiotherapy: the Virtual 4D PET Strategy 105
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged levothyroxine withdrawal. 104
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 104
CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer 103
The relationship between maternal relaxation and plasma beta-endorphin levels during parturition 103
[Primary empty sella syndrome. Clinical and radiological study, and evaluation of pituitary function] 103
Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings 101
Serum interleukin-6 levels in uterine malignancies. Preliminary data 101
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer] 101
Functional Imaging and Peptide Receptor Radionuclide Therapy 101
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 100
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training 100
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. 100
Autonomous thyroid nodule and percutaneous ethanol injection [letter] [see comments] 99
Hypothalamo-pituitary function in four cases of true precocious puberty 99
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer 98
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation 98
[Growth factors and oncogenes in development and carcinogenesis. Role of the epidermal growth factor system] 98
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix 97
Tumor-associated trypsin inhibitor (TATI) and renal function 97
Can insulin action induce myocardial texture alterations in essential hypertension? 97
Circulating levels of IGF-I in patients with chronic uremia on conservative dietary treatment. 97
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer 96
Effects of the ablation of the submaxillary gland on the rat testis 96
Plasma leptin levels in newborns from normal and diabetic mothers. 96
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders 95
Relationship between the circulating levels of adenohypophyseal hormones in blood and in cerebrospinal fluid 95
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 95
Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors 94
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses 94
Serum tumour-associated trypsin inhibitor (TATI) and renal function 94
Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. 94
RET mutation and increased angiogenesis in medullary thyroid carcinomas 94
T-helper 1 and 2 activation with fresh or cultured allo- or xenoislets 93
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary] 93
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). 93
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer 92
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer 92
Radioimmunoassay of unconjugated and total serum estetrol using a 125I-iodinated tracer 92
Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. 92
Anticlastogenic Effect of Ginkgo biloba Extract in Graves' Disease Patients Receiving Radioiodine Therapy 92
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer 89
Determination of serum levels of different cytokeratins in patients with uterine malignancies 89
Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia 89
Hyperprolactinemic amenorrhea induced by an intrasellar epithelial cyst 89
Soluble interleukin-2 receptor release during culture of human lymphocytes with human, porcine, or bovine islets and the effect of culture and cryopreservation 88
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma 88
Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations 88
External quality control survey for alpha-fetoprotein assay 88
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma 87
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary] 87
Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease. 87
Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. 87
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? 87
Anomalous between-laboratory variability in a collaborative study of carcinoembryonic antigen immunoassay [letter] 86
High-performance liquid chromatographic separation of iodoamino acids for tracer turnover studies of thyroid hormones in vivo 86
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma 85
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin 85
Total and free (dialyzable) cortisol assay in plasma: comparison of two RIA methods involving the use of antibody-coated test tubes 85
A computer program for customized recommendations to radioiodine-treated patients [Studio e realizzazione di un programma computerizzato per prescrizioni personalizzate a pazienti iodiotrattati in dimissione] 85
Human placental lactogen (hPL) deficiency in a normal pregnancy 84
Radioimmunoassay of free cortisol with antiserum-coated tubes and 125I-labeled cortisol [letter] 84
Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects. 84
Preoperative serum E-cadherin assay in patients with ovarian carcinoma 83
Serum soluble interleukin-2 receptor assay in epithelial ovarian cancer 83
Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration 83
Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism 83
Comet assay on children's leukocytes 8 years after the Chernobyl disaster 82
Relationship between pain sensitivity, cardiovascular reactivity to cold pressor test and indexes of activity of the adrenergic and opioid system 82
Preoperative evaluation of CA 125 and CA 19-9 serum levels in patients with ovarian masses 82
Human seminal transferrin: correlation with seminal and hormonal parameters 82
Multiple radioimmunological determinations of free (diffusible) steroid hormones (cortisol, progesterone, 17alpha OH-progesterone and estradiol) in the same plasma dialyzate after equilibrium dialysis 82
Totale 10.141
Categoria #
all - tutte 59.433
article - articoli 56.492
book - libri 0
conference - conferenze 1.997
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 944
Totale 118.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.308 0 0 78 175 221 206 10 171 162 5 201 79
2021/2022955 38 121 7 37 35 24 13 81 81 49 127 342
2022/20232.784 228 176 256 505 351 599 15 238 274 17 85 40
2023/20241.097 79 143 109 257 86 136 24 35 7 13 115 93
2024/20252.780 250 192 31 497 158 39 30 165 506 168 228 516
2025/20261.707 683 459 565 0 0 0 0 0 0 0 0 0
Totale 16.134